mcnaso they are putting whole mcna on shelf? with so many years of research and being asked to conduct second phase 3 which is not reasonable in pharma world? what about immunocidin ability to speed up recovery? and they want to purchase pre clinical platform. WTF. why would ipsen return rights outright, if platform is not doomed (MCNA was not rejected by FDA, asked to do more testing in additional second p3.>